Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Features of microsurgical treatment in patients with pterygium

Show simple item record

dc.contributor.author Fandofan, Victoria
dc.contributor.author Bozul, Uliana-Ariadna
dc.contributor.author Jeru, Ion
dc.date.accessioned 2024-04-29T07:11:56Z
dc.date.available 2024-04-29T07:11:56Z
dc.date.issued 2024
dc.identifier.citation FANDOFAN, Victoria, BOZUL, Uliana-Ariadna, JERU, Ion. Features of microsurgical treatment in patients with pterygium. In: Cells and Tissues Transplantation. Actualities and Perspectives: the materials of the nat. scientific conf. with internat. particip., the 2nd ed. Chisinau, March 29-30th 2024: [abstracts]. Chişinău: CEP Medicina, 2024, p. 33. ISBN 978-9975-82-366-1. en_US
dc.identifier.isbn 978-9975-82-366-1
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/27044
dc.description.abstract Bakground. Pterygium is clinically manifested by a triangular fold of the bulbar conjunctiva with the base towards the semilunar fold and the tip towards the cornea. The etiology and pathogenesis of pterygium is unknown. It would result from a corneo-conjunctival epithelial alteration, associated with a proliferation of fibrinogen tissue, progressing between the epithelium reduced to a few layers of cells and the perforated Bowman's membrane. Aim. To assess the effectiveness of a modified method in the treatment of pterygium,stage II. Objectives.1. To determine the effectiveness of the modified method using the free conjunctival flap plus subconjunctival administration of 5-FU (fluoruracil) in the treatment of patients with pterygium. 2. To appreciate the benefits of the modified method depending on the addressability of patients with pterygium. Materials and methods. The study included 8 patients (4 men and 4 women) with pterygium aged 20-71 years who underwent pterygium removal according to a modified method. Thus, during the surgical intervention, a movable, free, rectangular flap with sides 5 x 3 mm was prepared inferiorly paralimbally, which was fixed conjunctivally paralimbally, nasally in the area of the body of the pterygium translocated to the superior or inferior fornix plus subconjunctival administration of 5-FU . It is important to position the formed conjunctival flap with a limbal orientation. Discussions. The postoperative recovery was fast, but for several days after the operation the globe was hyperemic, irritating the suture fibers used to fix the conjunctival autograft. Antibiotic and anti- inflammatory in the form of eye drops are needed. Thus, in all patients, 3 months after the microsurgical intervention, no signs of recurrence of the operated pterygium were detected. In 2 late- presenting patients, the pterygium was extended onto the cornea, resulting in deep scarring. As a consequence, the radius of corneal curvature was changed with the decrease in visual acuity in the postoperative period. This is why surgery for pterygium should not have been delayed. Conclusions: 1. The microsurgical method proposed for the treatment of pterygium is safe and effective, determining the lack of recurrence in the postoperative period. 2. Microsurgical intervention based on pterygium should be performed as early as possible. en_US
dc.language.iso en en_US
dc.publisher CEP Medicina en_US
dc.relation.ispartof Cells and tissues transplantation. Actualities and perspectives. The 2-nd edition. Chisinau, March 29-30th 2024 en_US
dc.subject recurrent pterygium en_US
dc.subject free conjunctival flap en_US
dc.subject recurrence en_US
dc.subject postoperative period en_US
dc.subject 5-FU (fluoruracil) en_US
dc.title Features of microsurgical treatment in patients with pterygium en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics